Dear Investors,
Our Paid Members have another reason to CHEER. Our Recommended CADILA HEALTHCARE at 310 levels has given 50% returns so far....at CMP 465
I have also mentioned it many times in this BLOG..but only when you'll see it flying then you want to CATCH IT....instead try to catch it before it takes off..to get the MAXIMUM BENEFIT !!" Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In India, Cadila consolidated its position with the acquisition of Recon Healthcare and German Remedies. In the international markets, the company had adopted the strategy of competing directly in the generics market and also focusing on contract manufacturing. As part of its generics strategy, Cadila acquired Alpharma’s arm in France in 2003 to foray into the French generics market and also started filing its own ANDAs for the US market. On the contract manufacturing front, Cadila has a JV with Nycomed for the latter’s drug ‘Protonix’ and has also entered into more such contracts with other innovator companies, one of them being a JV with Hospira. In FY09, Cadila demerged its consumer healthcare business into a separate listed company called Zydus Wellness Ltd, in which the former holds a stake of around 72%. "
OUR ANOTHER HIDDEN GEM HAS ALSO TAKEN OFF...GRAB IT NOW. Rush ur mails to sokhitrading@gmail.com
No comments:
Post a Comment